Abstract
Over-expression of the proto-oncogene pleomorphic adenoma gene 1 (PLAG1) plays a crucial role in the formation of pleomorphic adenoma, which is the most common type of salivary gland tumor. To understand the molecular mechanisms governing PLAG1-mediated tumorigenesis, we used a microarray-based approach to identify PLAG1 target genes. We validated the expression of several genes, including Bax, Fas, p53, p21, p16, Cyclin D1, Egfr, Trail-R/DR5, c-Fos, c-myc and Igf2, by real-time RT-PCR or western blotting. Using luciferase reporter gene assays, we determined that the promoters of Bax, Fas, p53, TRAIL-R/DR5, and c-Fos were transactivated by PLAG1. PLAG1 not only activates genes that promote cell proliferation and tumor formation but also genes that inhibit these cellular processes. Therefore, we conclude that PLAG1 may play a dual role in tumor formation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Azuma M, Kasai Y, Tamatani T, Sato M (1992) Involvement of p53 mutation in the development of human salivary gland pleomorphic adenomas. Cancer Lett 65(1):61–71
Bartkova J, Horejsí Z, Koed K, Krämer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, Ørntoft T, Lukas J, Bartek J (2005) DNA damage response as a candidate anticancer barrier in early human tumorigenesis. Nature 434:864–870
Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, Green DR (2004) Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303(5660):1010–1014
Enlund F, Nordkvist A, Sahlin P, Mark J, Stenman G (2002) Expression of PLAG1 and HMGIC proteins and fusion transcripts in radiation-associated pleomorphic adenomas. Int J Oncol 20:713–716
Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA Jr, Kastrinakis NG, Levy B, Kletsas D, Yoneta A, Herlyn M, Kittas C, Halazonetis TD (2005) Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434:907–913
Grabowski P, Sturm I, Schelwies K, Maaser K, Buhr HJ, Dörken B, Zeitz M, Daniel PT, Scherübl H (2006) Analysis of neuroendocrine differentiation and the p53/BAX pathway in UICC stage III colorectalcarcinoma identifies patients with good prognosis. Int J Colorectal Dis 21(3):221–230
Landrette SF, Kuo YH, Hensen K, Khosrovani B, Perrat PN, Van de Ven WJ, Delwel R, Castilla LH (2005) Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11. Blood 105:2900–2907
Nehls O, Okech T, Hsieh CJ, Sarbia M, Borchard F, Gruenagel HH, Gaco V, Porschen R, Gregor M, Klump B (2005) Low BAX protein expression correlates with disease recurrence in preoperatively irradiated rectal carcinoma. Int J Radiat Oncol Biol Phys 61(1):85–91
Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM, Meltzer PS (2003) High frequency of BRAF mutations in nevi. Nat Genet 33:19–20
Schelwies K, Sturm I, Grabowski P, Scherübl H, Schindler I, Hermann S, Stein H, Buhr HJ, Riecken EO, Zeitz M, Dörken B, Daniel PT (2002) Analysis of p53/BAX in primary colorectal carcinoma: low BAX protein expression is a negative prognostic factor in UICC stage III tumors. Int J Cancer 99(4):589–596
Shen S, Yang W, Wang Z, Lei X, Xu L, Wang Y, Wang L, Huang L, Yu Z, Zhang X, Li J, Chen Y, Zhao X, Yin X, Zhang C (2011) Tumor-initiating cells are enriched in CD44(hi) population in murine salivary gland tumor. PLoS ONE 6(8):e23282
Sturm I, Köhne CH, Wolff G, Petrowsky H, Hillebrand T, Hauptmann S, Lorenz M, Dörken B, Daniel PT (1999) Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases. J Clin Oncol 17(5):1364–1374
Tarakji B, Kujan O, Nassani MZ (2010) Immunohistochemical expression of p53 in pleomorphic adenoma and carcinoma ex pleomorphic adenoma. J Cancer Epidemiol 2010:250606
Voz ML, Agten NS, Van de Ven WJ, Kas K (2000) PLAG1 The main translocation target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II. Cancer Res 60:106–113
Voz ML, Mathys J, Van de Ven WJ et al (2004) Microarray screening for target genes of the proto-oncogene PLAG1. Oncogene 23(1):179–191
Wu GS, Kim K, el-Deiry WS (2000) KILLER/DR5 a novel DNA-damage inducible death receptor gene, links the p53-tumor suppressor to caspase activation and apoptotic death. Adv Exp Med Biol 465:143–151
Zhao X, Ren W, Yang W, Wang Y, Kong H, Wang L, Yan L, Xu G, Fei J, Fu J, Zhang C, Wang Z (2006) Wnt pathway is involved in pleomorphic adenomas induced by overexpression of PLAG1 in transgenic mice. Int J Cancer 118(3):643–648
Acknowledgments
This work was supported by the National Natural Science Foundation of China 30772432 and 30772430.
Author information
Authors and Affiliations
Corresponding author
Additional information
Yang Wang and Wenjun Shang contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wang, Y., Shang, W., Lei, X. et al. Opposing functions of PLAG1 in pleomorphic adenoma: a microarray analysis of PLAG1 transgenic mice. Biotechnol Lett 35, 1377–1385 (2013). https://doi.org/10.1007/s10529-013-1213-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-013-1213-7